| Name | Title | Contact Details |
|---|
Ritter Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem (digestive tract). Ritter Pharmaceuticals, Inc. is rapidly establishing itself as the world`s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field. RP-G28, Ritter`s lead product, has been studied in a Phase 2 trial and is a first-in-class compound. RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease which affects over 1 billion people worldwide.
LIFE Corporation is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
China Aoxing Pharmaceutical Company is a Jersey City, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SouthLight Healthcare is a nonprofit organization that provides outpatient and community-based services for mental health and substance use treatment. They empower the journey through prevention, education, and innovative treatment solutions delivered ...
Santo Remedio is a Hispanic health and wellness startup that creates supplements and communities focused on preventative solutions to health problems, tailored to individual needs.